Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00322374
Status:
COMPLETED
Last Update Posted:
2016-03-10
First Post:
2006-05-01
Brief Title:
Phase I Combination w Epirubicin
Sponsor:
R-Pharm
Organization:
R-Pharm
Organization Data
Organization:
R-Pharm
Class:
INDUSTRY
Study ID:
CA163-104
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
R-Pharm
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None